Contrast-Enhanced FDG-PET/CT vs. SPIO-Enhanced MRI vs. FDG-PET vs. CT in Patients with Liver Metastases from Colorectal Cancer: A Prospective Study with Intraoperative Confirmation

References

• Abdel-Nabi H., Doerr R. J., Lamonica D. M., Cronin V. R., Galantowicz P. J., Carbone G. M., et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 1998; 206: 755–60
   PubMed Web of Science ®Google Scholar
• Akhurst T., Kates T. J., Mazumdar M., Yeung H., Riedel E. R., Burt B. M., et al. Recent chemotherapy reduces the sensitivity of [18F] fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. J Clin Oncol 2005; 23: 8713–6
   PubMed Web of Science ®Google Scholar
• Ba-Ssalamah A., Heinz-Peer G., Schima W., Schibang N., Schick S., Prokesch R. W., et al. Detection of focal hepatic lesions: comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP. J Magn Reson Imaging 2000; 11: 665–72
   PubMed Web of Science ®Google Scholar
• Berthelsen A. K., Holm S., Loft A., Klausen T. L., Andersen F., Hojgaard L. PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients. Eur J Nucl Med Mol Imaging 2005; 32: 1167–75
   PubMed Web of Science ®Google Scholar
• Bipat S., van Leeuwen M. S., Comans E. F. I., Pijl M. E., Killius J., Clavien P. A., et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis—meta-analysis. Radiology 2005; 237: 123–31
   PubMed Web of Science ®Google Scholar
• Blakeborough A., Ward J., Wilson D., Griffith S. M., Kajiya Y., Guthrie J. A., et al. Hepatic lesion detection at MR imaging: a comparative study with four sequences. Radiology 1997; 203: 759–65
   PubMed Web of Science ®Google Scholar
• Blokhuis T. J., van der Schaaf M. C., van den Tol M. P., Comans E. F. I., Manoliu R. A., van der Sijp J. R. M. Results of radio frequency ablation of primary and secondary liver tumors: long-term follow-up with computed tomography and positron emission tomography-18F-deoxyfluoroglucose scanning. Scand J Gastroenterol 2004; 39( Suppl 241)93–7
   PubMed Web of Science ®Google Scholar
• Böhm B., Voth M., Geoghegan J., Hellfritzsch H., Petrovich A., Scheele J., et al. Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors. J Cancer Res Clin Oncol 2004; 130: 266–72
   PubMed Web of Science ®Google Scholar
• Cohade C., Osman M., Leal J., Wahl R. L. Direct comparison of 18F-FDG-PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 2003; 44: 1797–803
   PubMed Web of Science ®Google Scholar
• Delbelke D., Vitola J. V., Sandler M. P., Arildsen R. C., Powers T. A., Wright J. K., Jr., et al. Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 1997; 38: 1196–201
   PubMed Web of Science ®Google Scholar
• Flanagan F. L., Dehdashti F., Ogunbiyi A., Kodner I. J., Siegel B. A. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 1998; 227: 319–23
   PubMed Web of Science ®Google Scholar
• Fong Y., Saldinger P. F., Akhurst T., Macapinlac H., Yeung H., Finn R. D., et al. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 1999; 178: 282–7
   PubMed Web of Science ®Google Scholar
• Furuhata T., Okita K., Tsuruma T., Hata F., Kimua Y., Katsuramaki T., et al. Efficacy of SPIO-MR imaging in the diagnosis of liver metastases from colorectal carcinomas. Dig Surg 2003; 20: 321–5
   PubMed Web of Science ®Google Scholar
• Huebner R. H., Park K. C., Shepherd J. E., Schwimmer J., Czernin J., Phelps M. E., et al. A meta-analysis of the literature for whole-body PET detection of recurrent colorectal cancer. J Nucl Med 2000; 41: 1177–89
   PubMed Web of Science ®Google Scholar
• Imdahl A., Reinhardt M. J., Nitzsche E. U., Mix M., Dingeldey A., Einert A., et al. Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences. Arch Surg 2000; 385: 129–34
   Google Scholar
• Kim M. J., Mitchell D. G., Ito K., Kim P. N. Hepatic MR imaging: comparison of 2D and 3D gradient echo techniques. Abdom Imaging 2001; 26: 269–76
   PubMedGoogle Scholar
• Kim S. H., Choi D., Kim S. H., Lim J. H., Lee W. J., Kim M. J., et al. Ferucarbotran-enhanced MRI versus triple- phase MDCT for the preoperative detection of hepatocellular carcinoma. Am J Roentgenol 2005; 184: 1069–76
   PubMed Web of Science ®Google Scholar
• Kinkel K., Lu Y., Both M., Warren R. S., Thoeni R. F. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR Imaging, PET): a meta-analysis. Radiology 2002; 224: 748–56
   PubMed Web of Science ®Google Scholar
• Kuszyk B. S., Bluemke D. A., Urban B. A., Choti M. A., Hruban R. H., Sitzmann J., et al. Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings. Am J Roentgenol 1996; 166: 91–5
   PubMed Web of Science ®Google Scholar
• Lai D. T. M., Fulham M., Stephen M. S., Chu K. M., Solomon M., Thompson J. F., et al. The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 1996; 131: 703–7
   PubMedGoogle Scholar
• Numminen K., Isoniemi H., Halavaara J., Tervahartiala P., Makusalo H., Laasonen L., et al. Preoperative assessment of focal liver lesions: multidetector computed tomography challenges magnetic resonance imaging. Acta Radiol 2005; 46: 9–15
   PubMed Web of Science ®Google Scholar
• Reimer P., Jähnke N., Fiebich M., Schima W., Deckers F., Marx C., et al. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 2000; 217: 152–8
   PubMed Web of Science ®Google Scholar
• Rohren E. M., Paulson E. K., Hagge R., Wong T. Z., Killius J., Clavien P. A., et al. The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer. Clin Nucl Med 2002; 27: 550–5
   PubMed Web of Science ®Google Scholar
• Ruers T. J. M., Langenhoff B. S., Neeleman N., Jager G. J., Strijk S., Wobbes T., et al. Value of positron emission tomography with [F-18] fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 2002; 20: 388–95
   PubMed Web of Science ®Google Scholar
• Rydzewski B., Dehdashti F., Gordon B. A., Teefey S. A., Strasberg S. M., Siegel B. A. Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET. Am J Roentgenol 2002; 178: 353–8
   PubMed Web of Science ®Google Scholar
• Scott D. J., Guthrie J. A., Arnold P., Ward J., Atchley J., Wilson D., et al. Dual phase helical CT versus portal venous phase CT for the detection of colorectal liver metastases; correlation with intra-operative sonography, surgical and pathological finings. Clin Radiol 2001; 56: 235–42
   PubMed Web of Science ®Google Scholar
• Selzner M., Hany T. F., Wildbrett P., McCormack L., Kadry Z., Clavien P. A. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?. Ann Surg 2004; 240: 1027–36
   PubMed Web of Science ®Google Scholar
• Semelka R. C., Cance W. G., Marcos H. B., Mauro M. A. Liver metastases: comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases. Radiology 1999; 213: 86–91
   PubMed Web of Science ®Google Scholar
• Truant S., Huglo D., Hebbar M., Ernst O., Steinling M., Pruvot F. R. Prospective evaluation of the impact of [18F]fluoro-2-deoxyglucose positron emission tomography of resectable colorectal liver metastases. Br J Surg 2005; 92: 362–9
   PubMed Web of Science ®Google Scholar
• Valls C., Andía E., Sánchez A., Guma A., Figueres J., Torras J., et al. Hepatic metastases from colorectal cancer: preoperative assessment of resectability with helical CT. Radiology 2001; 218: 55–60
   PubMed Web of Science ®Google Scholar
• Valls C., Lopez E., Gumá A., Gil M., Sanchez A., Andia E., et al. Helical CT versus CT arterial portography in the detection of hepatic metastasis of colorectal carcinoma. Am J Roentgenol 1998; 170: 1341–7
   PubMed Web of Science ®Google Scholar
• Van Beers B. E., Lacrosse M., Jamart J., Grandin C., Gigot J. F., Horsmans Y., et al. Detection and segmental location of malignant hepatic tumors: comparison of ferumoxides-enhanced gradient-echo and T2-weighted spin-echo MR imaging. Am J Roentgenol 1997; 168: 713–7
   PubMed Web of Science ®Google Scholar
• Vitola J. V., Delbelke D., Sandler M. P., Campbell M. G., Powers T. A., Wright J. K., et al. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 1996; 171: 21–6
   PubMed Web of Science ®Google Scholar
• Vogl T. J., Schwarz W., Blume S., Pietsch M., Shamsi K., Franz M., et al. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US. Eur Radiol 2003; 13: 262–72
   PubMed Web of Science ®Google Scholar
• Ward J., Chen F., Guthrie J. A., Wilson D., Lodge J. P., Wyatt J. I., et al. Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternate-free response receiver operating characteristic analyses. Radiology 2000; 214: 159–6
   PubMed Web of Science ®Google Scholar
• Ward J., Naik K. S., Ashley Guthrie J., Wilson D., Robinson P. J. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 1999; 210: 459–66
   PubMed Web of Science ®Google Scholar
• Ward J., Robinson P. J., Ashley Guthrie J., Downing S., Wilson D., Lodge J. P., et al. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology 2005; 237: 170–80
   PubMed Web of Science ®Google Scholar